Other Species / Isoforms
  ZNF329 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S50
QEGHLRQSALTLEKP
0 3
ZNF329 (human) QEGHLRQSALTLEKP S50
ZNF329 (mouse) QERNLRQsPLIDEKT S30-p
K127-ub
GDSDACGkGFNHSME
0 1
ZNF329 (human) GDSDACGkGFNHSME K127-ub
ZNF329 (mouse) ADGDACEKATQPSME K107
K148-ub
PVREKPYkYPESVKS
0 1
ZNF329 (human) PVREKPYkYPESVKS K148-ub
ZNF329 (mouse) QMREKSYKYTESVKS K129
S241-p
NECGKSFsKNYNLIV
0 1
ZNF329 (human) NECGKSFsKNYNLIV S241-p
ZNF329 (mouse) NDCGKSFSKNYNLIV S222
K257
QRIHTGEKPYECSKC
0 2
ZNF329 (human) QRIHTGEKPYECSKC K257
ZNF329 (mouse) RRIHTGEkPYKCSKC K238-ub
K313-ac
QRTHTGEkPYRCNEC
0 3
ZNF329 (human) QRTHTGEkPYRCNEC K313-ac
ZNF329 (mouse) QRTHTGEKPYRCNEC K294
S496-p
GKSFKQNsHLAVHQR
Upstream
0 2
Treatment
  • selumetinib
  • vemurafenib
ZNF329 (human) GKSFKQNsHLAVHQR S496-p
ZNF329 (mouse) GKSFRQNTHLVVHQR T477